ImageneBio, Inc.
IMA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001835579
In the last 90 days, ImageneBio, Inc. insiders filed 0 open-market purchases and 1 sale; 35 institutions reported holding it in 13F filings for Q2 2026, worth $36.8M in total; no superinvestor holds it.
13F holders, Q3 2022
Institutional positions in ImageneBio, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 42
- −3 vs. Q2 2022
- Shares held
- 26.2M
- −539.6K (−2.0%) vs. Q2 2022
- Total value
- $93.2M
- −$25.5M (−21.5%) vs. Q2 2022
- New holders
- 5
- 18 more added
- Sold out
- 8
- 7 more reduced
1 institution that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IMA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 35 | $36.8M |
| Q1 2026 | 39 | $26.8M |
| Q4 2025 | 41 | $32.9M |
| Q3 2025 | 33 | $38.3M |
| Q2 2025 | 41 | $42.6M |
| Q1 2025 | 46 | $41.9M |
| Q4 2024 | 53 | $52.0M |
| Q3 2024 | 57 | $49.1M |
| Q2 2024 | 70 | $47.9M |
| Q1 2024 | 57 | $42.7M |
| Q4 2023 | 54 | $63.8M |
| Q3 2023 | 58 | $141.6M |
| Q2 2023 | 52 | $204.7M |
| Q1 2023 | 39 | $86.2M |
| Q4 2022 | 34 | $69.9M |
| Q3 2022 | 42 | $93.2M |
| Q2 2022 | 46 | $118.7M |
| Q1 2022 | 48 | $167.8M |
| Q4 2021 | 49 | $343.6M |
| Q3 2021 | 39 | $271.8M |
| Q2 2021 | 42 | $293.2M |
| Q1 2021 | 27 | $538.5M |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding ImageneBio, Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Daiwa Securities Group Inc. | 105 | $0 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 231 | $1.00K | 0.00% | +36+18.5% | Added |
| Wells Fargo & Company | 266 | $1.00K | 0.00% | +103+63.2% | Added |
| China Universal Asset Management Co., Ltd. | 340 | $1.00K | 0.00% | +340 | New |
| Citigroup Inc | 679 | $2.00K | 0.00% | −257−27.5% | Reduced |
| Bank of America Corp | 617 | $2.00K | 0.00% | +309+100.3% | Added |
| MUFG Americas Holdings Corp | 450 | $2.00K | 0.00% | +450 | New |
| BNP Paribas Arbitrage, SA | 976 | $3.46K | 0.00% | +976 | New |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 2,472 | $9.00K | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 2,445 | $9.00K | 0.00% | +1,071+77.9% | Added |
| Baystate Wealth Management LLC | 2,999 | $11.0K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 3,842 | $13.0K | 0.00% | +679+21.5% | Added |
| Charles Schwab Investment Management Inc | 12,066 | $43.0K | 0.00% | +12,066 | New |
| Goldman Sachs Group Inc | 12,428 | $44.0K | 0.00% | −11,142−47.3% | Reduced |
| Acadian Asset Management LLC | 13,301 | $45.0K | 0.00% | +3,103+30.4% | Added |
| Qube Research & Technologies Ltd | 19,201 | $68.0K | 0.00% | −5,131−21.1% | Reduced |
| Dimensional Fund Advisors LP | 25,145 | $90.0K | 0.00% | +15,013+148.2% | Added |
| Northern Trust Corp | 27,234 | $97.0K | 0.00% | +11,800+76.5% | Added |
| Cornercap Investment Counsel Inc | 29,465 | $105.0K | 0.02% | +12,829+77.1% | Added |
| State Street Corp | 31,553 | $112.0K | 0.00% | −12,703−28.7% | Reduced |
| Morgan Stanley | 51,515 | $183.0K | 0.00% | −23,592−31.4% | Reduced |
| Ensign Peak Advisors, Inc | 90,310 | $321.0K | 0.00% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 91,800 | $326.0K | 0.01% | +78,800+606.2% | Added |
| Ergoteles LLC | 100,640 | $357.0K | 0.01% | −15,401−13.3% | Reduced |
| DAFNA Capital Management LLC | 122,517 | $435.0K | 0.12% | +122,517 | New |
| Oasis Management Co Ltd. | 140,000 | $497.0K | 0.09% | 00.0% | Unchanged |
| Barclays PLC | 201,227 | $714.0K | 0.00% | +132+0.1% | Added |
| HealthCor Management, L.P. | 220,082 | $781.0K | 0.10% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 236,948 | $841.0K | 0.00% | +134,274+130.8% | Added |
| BlackRock Inc. | 502,152 | $1.78M | 0.00% | +214,404+74.5% | Added |
| Laurion Capital Management LP | 529,000 | $1.88M | 0.05% | 00.0% | Unchanged |
| Vanguard Group Inc | 979,003 | $3.48M | 0.00% | +304,898+45.2% | Added |
| CHI Advisors LLC | 1,214,304 | $4.31M | 1.16% | +123,367+11.3% | Added |
| Verition Fund Management LLC | 1,299,255 | $4.61M | 0.06% | +277,365+27.1% | Added |
| Point72 Asset Management, L.P. | 1,343,496 | $4.77M | 0.02% | +654,800+95.1% | Added |
| Artal Group S.A. | 1,549,513 | $5.50M | 0.29% | 00.0% | Unchanged |
| Citadel Advisors LLC | 2,158,479 | $7.66M | 0.01% | +32,078+1.5% | Added |
| Omega Fund Management, LLC | 2,249,123 | $7.98M | 2.92% | 00.0% | Unchanged |
| BVF Inc | 2,503,071 | $8.89M | 0.37% | 00.0% | Unchanged |
| FMR LLC | 2,526,203 | $8.97M | 0.00% | −1,869,516−42.5% | Reduced |
| OrbiMed Advisors LLC | 2,933,941 | $10.4M | 0.21% | 00.0% | Unchanged |
| Atlas Venture Life Science Advisors, LLC | 5,018,178 | $17.8M | 1.97% | 00.0% | Unchanged |
| Farallon Capital Management, L.L.C. | 0 | $0 | 0.00% | −290,000−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −235,818−100.0% | Sold out |
| Jacobs Levy Equity Management, Inc | 0 | $0 | 0.00% | −40,915−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −20,720−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −15,544−100.0% | Sold out |
| New York State Common Retirement Fund | 0 | $0 | 0.00% | −201−100.0% | Sold out |
| Credit Suisse AG | 0 | $0 | 0.00% | −15−100.0% | Sold out |
| Capital Advisors, Ltd. LLC | 0 | $0 | 0.00% | −27−100.0% | Sold out |
| Private Capital Group, LLC | – | – | – | – | Not filed |